Biodegradable-polymer stents versus durable-polymer stents
Lancet
.
2019 May 11;393(10184):1932-1933.
doi: 10.1016/S0140-6736(19)30023-6.
Authors
Lee-Jen Wei
1
,
Ryan Sun
2
,
Ariela R Orkaby
3
,
Dae Hyun Kim
4
,
Huili Zhu
5
Affiliations
1
Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA 02115, USA. Electronic address: wei@hsph.harvard.edu.
2
Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA 02115, USA.
3
New England GRECC, VA Boston Healthcare System, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
4
Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
5
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
PMID:
31084958
DOI:
10.1016/S0140-6736(19)30023-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Absorbable Implants
Drug-Eluting Stents*
Everolimus
Percutaneous Coronary Intervention*
Polymers
Sirolimus
Stents
Substances
Polymers
Everolimus
Sirolimus